Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
TargetMol | Compound Library

Anti-Ovarian Cancer Compound Library

Catalog No. L2196

Ovarian cancer is a malignant tumor that develops in the ovarian tissue. Approximately 90% to 95% of ovarian cancers are primary, meaning they form within the ovaries, while the remaining 5% to 10% are metastatic cancers that have spread to the ovaries from other sites. Early-stage ovarian cancer typically presents with no distinct symptoms, and even when symptoms are present, they lack specificity, making early diagnosis relatively challenging. About 60% to 70% of patients are diagnosed at an advanced stage with poor treatment outcomes. Although the occurrence of ovarian cancer is lower than that of cervical and endometrial cancers, its mortality rate is much higher. Ovarian cancer ranks as the leading cause of mortality among malignant tumors of the female reproductive tract, and mortality rate has been on the rise, posing a significant threat to women's health. Effectively improving the survival period of ovarian cancer patients has become a pressing challenge. In recent years, there has been remarkable progress in the development of molecular targeted therapies. It's shown that targeted drugs for the ovarian cancer play a significant role in enhancing patient survival. The development of targeted therapies has brought hope to ovarian cancer patients, offering them more effective treatment strategies. The TargetMol anti-ovarian cancer compound library comprises a collection of Xnum compounds, including compounds reported to exhibit therapeutic effects against ovarian cancer as well as compounds with the potential for treating ovarian cancer. The library serves as a valuable tool for the research and development of anti-ovarian cancer drugs.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.

Resource Download
Library compound info
Excel
SDF
Contact us for more batch information

Catalog No. L2196

Anti-Ovarian Cancer Compound Library

sizeIn stock

  • 1 mg
  • 30 μL x 10 mM (in DMSO)
  • 50 μL x 10 mM (in DMSO)
  • 100 μL x 10 mM (in DMSO)
  • 250 μL x 10 mM (in DMSO)
Inquiry & Custom

Top Publication Citing
Use of TargetMol Products

Cite scientific literature on TargetMol products

View More

Product Description Product Description

  • A unique collection of 2232 compounds with anti-ovarian cancer therapeutic activity, can be used for anti-ovarian cancer drug discovery and pharmacological study;
  • Targets include PARP, VEGF, PD-1, HER2, etc;
  • Some compounds have already been launched or are in clinical phases.
  • Detailed compound information on structures, targets, IC50 and activity descriptions.
  • NMR and HPLC/LCMS validated to ensure high purity and quality.

Packaging And Storage Packaging And Storage

  • Powder or pre-dissolved DMSO solutions in 96/384 well plate with optional 2D barcode
  • Shipped with blue ice
  • This compound library is provided at a concentration of 10 mM in DMSO. A small number of compounds may be provided in different solvents or concentrations due to solubility or stability requirements. Please refer to the specific product information for details.

Library Customization | TargetMol Library Customization

Compound Library | TargetMol
Targetmol Compound Libraries
can be highly customized!
Inquiry & Custom

Sci Citations

Library Customization | TargetMol Library Composition

Apoptosis
NF-κB
Autophagy
PI3K
EGFR
Reactive Oxygen Species
VEGFR
Wnt/beta-catenin
mTOR
p38 MAPK
Akt
ERK
Estrogen Receptor/ERR
PARP
Endogenous Metabolite
AMPK
GSK-3
Antibacterial
Raf
TGF-beta/Smad
CDK
PDGFR
MAPK
Estrogen/progestogen Receptor
JNK
Ras
IκB/IKK
MEK
TNF
FGFR
COX
c-Kit
Src
FLT
DNA-PK
RIP kinase
NOD
S6 Kinase
Parasite
ATM/ATR
HER
ALK
Antioxidant
Caspase
STAT
c-Met/HGFR
PKC
IL Receptor
PDK
IRAK
Antifungal
DNA/RNA Synthesis
Influenza Virus
Ferroptosis
Topoisomerase
Antibiotic
PPAR
Cytochromes P450
c-RET
HIV Protease
Calcium Channel
PKA
JAK
Potassium Channel
NO Synthase
Rho
Kras
PI4K
Bcr-Abl
Aurora Kinase
Bcl-2 Family
Nrf2
Casein Kinase
Mitophagy
MMP
IGF-1R
ROS
NOD-like Receptor (NLR)
Mitochondrial Metabolism
Dehydrogenase
Tyrosine Kinases
Chk
Lipoxygenase
MNK
Microtubule Associated
FAK
p53
TLR
c-Fms
HDAC
AChR
HCV Protease
Virus Protease
HIF/HIF Prolyl-Hydroxylase
MLK
NOS
ROCK
PTEN
Epigenetic Reader Domain
HSP
Beta Amyloid
GABA Receptor
Sodium Channel
Phosphatase
SIK
PDE
Drug Metabolite
Interleukin
Antiviral
Syk
TAM Receptor
Tyrosinase
Antifection
Cholinesterase (ChE)
P-gp
Prostaglandin Receptor
Trk receptor
MELK
5-HT Receptor
Transferase
Tie-2
TRP/TRPV Channel
E1/E2/E3 Enzyme
HSV
Ephrin Receptor
ASK
HIF
Anti-infection
Proteasome
ATPase
Carbonic Anhydrase
Histone Methyltransferase
Integrin
DYRK
RAAS
TOPK
GTPase
c-Myc
Serine Protease
Serine/threonin kinase
Adrenergic Receptor
MAO
Aryl Hydrocarbon Receptor
LDL
Opioid Receptor
GluR
CaMK
Porcupine
Free radical scavengers
GPR
SGK
Cannabinoid Receptor
BTK
ADC Cytotoxin
Mdm2
PROTACs
Reductase
BACE
NADPH
Histamine Receptor
Progesterone Receptor
HBV
Pim
RANKL/RANK
IAP
CSF-1R
Gamma-secretase
Glucosidase
DNA Alkylation
cAMP
DUB
Androgen Receptor
PGE Synthase
transporter
Reverse Transcriptase
Aromatase
KLF
PLK
PD-1/PD-L1
S1P Receptor
Chloride channel
RAR/RXR
ROR
MyD88
DNA Alkylator/Crosslinker
LTR
IFNAR
Glutathione Peroxidase
MRP
AAK1
Nucleoside Antimetabolite/Analog
Liver X Receptor
Leukotriene Receptor
PYK2
Immunology/Inflammation related
Glucocorticoid Receptor
IRE1
Myosin
NMDAR
CCR
ACK1
Lipid
Beta-Secretase
Acyltransferase
SARS-CoV
STING
LRRK2
AIM2
PAI-1
RSV
GST
Retinoid Receptor
NADPH-oxidase
BMI-1
AhR
Apelin receptor
Proton pump
MicroRNA
Adenylyl Cyclase
NPC1L1
DHFR
Dopamine Receptor
YAP
Arginase
LPL Receptor
Adenosine Receptor
Histone Demethylase
PERK
Necroptosis
gp120/CD4
VDA
OCT
GNRH Receptor
Cholecystokinin Receptor
Cysteine Protease
LIM Kinase
Glucokinase
Stemness kinase
iGluR
PAFR
Haspin Kinase
Phosphorylase
Monoamine Transporter
Smo
Fatty Acid Synthase
Hedgehog/Smoothened
FAAH
CXCR
Somatostatin
Indoleamine 2,3-Dioxygenase (IDO)
SGLT
Wee1
ATP Citrate Lyase
OXPHOS
BCRP
Glutathione reductase
Aminopeptidase
Sirtuin
Histone Acetyltransferase
Decarboxylase
cGAS
Methionine Adenosyltransferase (MAT)
Hippo pathway
GPX
Ligand for E3 Ligase
CRISPR/Cas9
Phospholipase
Hydroxylase
RXFP receptor
Adenosine Deaminase
Discoidin Domain Receptor (DDR)
DAPK
Platelet aggregation
Protease-activated Receptor
ROS Kinase
CFTR
Kinesin
Monoamine Oxidase
PKM

Keywords